Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Rang in Aktien #27452
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Aktienkurs
$1.62
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$32.77M
Veränderung (1 Tag)
22.67%
Veränderung (1 Jahr)
-13.87%
Land
US
Handel AIxCrypto Holdings, Inc. (AIXC)

Kategorie

Kursverlauf für AIxCrypto Holdings, Inc. (AIXC)
Höchster Schlusskurs: $0.90 am 2026-08-01

Niedrigster Schlusskurs: $589.38K am 2015-06-01
Kursverlauf der Aktie von AIxCrypto Holdings, Inc. von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$61.63 67.11%
US
$51.71 74.55%
SE
$196.66 45.99%
FR
$119.62 69.92%
US
$62.87 2.86%
IT